The global cataract surgery devices market size was valued at USD 8.72 billion in 2025 and is projected to grow from USD 9.08 billion in 2026 to USD 12.54 billion by 2034, registering a CAGR of 4.12% during the forecast period (2026–2034). North America dominated the cataract surgery devices market with a share of 38.31% in 2025.
Cataract surgery devices are medical instruments and equipment used to remove the clouded natural lens of the eye and support the implantation of an artificial intraocular lens (IOL) to restore or improve vision. Cataract surgery devices are tracked under HSN Code 9018 (instruments and appliances used in medical and surgical sciences) and SIC Code 3845 (electromedical and electrotherapeutic apparatus).
The cataract surgery devices market demand is driven by the rising prevalence of cataracts, increasing number of cataract surgeries, and growing need for effective vision restoration. Healthcare providers are adopting advanced surgical instruments and phacoemulsification systems to improve surgical precision and patient outcomes, contributing to cataract surgery devices market growth.
2025 Market Size: USD 8.72 Billion
2026 Market Size: USD 9.07 Billion
2034 Projected Market Size: USD 12.54 Billion
Forecast Period: 2026–2034
Base Year: 2025
Market CAGR (2026–2034): 4.12%
Largest Regional Market (2025): North America
North America Market Share (2025): 38.31%
Fastest-Growing Region: Asia Pacific
Asia Pacific CAGR (2026–2034): 6.09%
By Product Type
Leading Segment: Intraocular Lenses
Market Share (2025): 36.7%
By End User
Fastest-Growing Segment: Ambulatory Surgical Centers
CAGR (2026–2034): 4.91%
Download a Free Sample To learn more about this report,
Advanced Intraocular Lenses for Cataract Surgery
The cataract surgery devices market analysis shows that it is evolving toward specialized intraocular lenses (IOLs). Options such as toric lenses and multifocal lenses are designed to address different visual needs after cataract removal. This trend is shaping lens selection around patients’ vision requirements.
Precision Ophthalmic Surgical Instruments
Cataract surgery is moving toward more precise ophthalmic surgical instruments. Improved instrument designs support accurate tissue handling and controlled lens removal during surgery. This trend is shaping surgical workflows toward greater precision and consistency.
Supply chain disruptions are expected to have a moderate impact on the cataract surgery devices market share, given its direct exposure to shortages of precision optical components, electronic systems, surgical instruments, and specialized consumables. The market is expected to experience a capacity-constrained recovery, as limited component availability and manufacturing capacity may delay device production and restrict the timely supply of surgical equipment. The market is projected to grow at a CAGR of 4.12%, but supply chain constraints could reduce growth by approximately 1.5 percentage points, resulting in short-term growth of around 2.62%. As supply conditions normalize through improved component availability, diversified sourcing, and more reliable manufacturing and distribution, market growth is expected to gradually return to 4.12%.
The cataract surgery devices market forecasts strategic investment activity directed toward intraocular lens development, laser-assisted cataract surgery, surgical equipment innovation, and the development of technologies that improve visual outcomes after surgery. In August 2026, Omega Ophthalmics raised USD 7 million in a Series A financing round led by a group of investors. The investment will support product development, regulatory activities, manufacturing scale-up, and clinical planning for its Gemini Refractive Capsule, an investigational intraocular lens platform designed for cataract surgery.
Precision Lens Removal and Intraocular Tissue Protection Drive Cataract Surgery Devices Market
The need for precise lens treatment during cataract removal is contributing to the use of femtosecond laser systems. These devices can create corneal incisions, perform capsulotomy, and fragment the cataractous lens before its removal. Their ability to automate selected surgical steps is supporting their use in cataract procedures where laser-assisted techniques are chosen. However, clinical evidence has not established superior overall outcomes compared with conventional surgery.
During cataract surgery, ophthalmic viscoelastic devices (OVDs) help maintain the anterior chamber and protect delicate eye tissues. These materials also facilitate surgical maneuvers, including capsulorhexis and intraocular lens placement. The need to preserve the eye’s internal structures and maintain a stable operating space supports the routine use of ophthalmic viscoelastic devices in cataract procedures.
Bleeding Risks and Drug Interaction Concerns Restrain Market Expansion
Antithrombotic drugs increase the risk of bleeding by reducing blood clot formation or preventing existing clots from growing. This risk can limit their use in patients with a history of bleeding or other conditions that increase bleeding complications. These concerns can restrict treatment eligibility and slow market expansion.
Potential drug interactions can complicate the use of antithrombotic drugs, particularly among patients taking multiple medications. Interactions with other medicines can increase bleeding risks or affect treatment effectiveness, requiring careful monitoring and dose adjustments. These requirements can increase the burden on healthcare providers and limit treatment adoption.
Premium Intraocular Lenses and Specialized Monofocal Lens Options Create Opportunities for Cataract Surgery Devices Market Players
Premium intraocular lenses (IOLs) offer opportunities for manufacturers to serve patients seeking vision correction beyond standard cataract treatment. Multifocal, extended depth of focus, and toric lenses can address needs such as near vision support, improved range of vision, or astigmatism correction. Medical device companies can expand their premium IOL portfolios to serve ophthalmologists and eye care centers offering a wider range of lens options.
Monofocal lenses provide another opportunity for opthalmology equipment and cataract surgery device manufacturers. These lenses offer clear vision at a single focal distance and remain a widely used option in cataract procedures. Manufacturers can develop monofocal IOLs with different material and design features to meet clinical requirements and provide options across a range of treatment settings.
Clinical Workflow Integration and Diagnostic Data Management Challenges Affect Critical Care Diagnostics Market Growth
Integrating critical care diagnostic systems into intensive care unit workflows can be challenging when multiple tests are performed across different departments and bedside settings. Coordinating sample collection, test processing, and result reporting among laboratory teams, nurses, and critical care physicians requires clear procedures. Differences in hospital workflows can complicate the consistent use of diagnostic systems across care units.
Managing the large volume of diagnostic data generated during critical care can also create difficulties for healthcare teams. Results from blood gas analysis, cardiac markers, coagulation tests, phacoemulsification, and other investigations may be recorded across separate systems. Consolidating these findings into a clear clinical view can be challenging, particularly when clinicians need to assess several indicators simultaneously.
The intraocular lenses segment accounted for a share of 36.7% in 2025, owing to their essential role in replacing the eye’s natural lens during cataract surgery. Their use in restoring vision after cataract removal supports the segment’s leading position.
The femtosecond laser systems segment is expected to grow at a CAGR of 5.62% during the forecast period. Their ability to support precise corneal incisions and lens fragmentation during cataract procedures supports segment growth.
Request Customizationto receive a tailored report.
The hospitals segment accounted for a share of 48.2% in 2025, owing to established surgical facilities and ability to manage a high volume of cataract procedures. Access to specialized ophthalmic equipment and surgical teams supports the segment’s leading position.
The ambulatory surgical centers segment is expected to grow at a CAGR of 4.91% during the forecast period, fueled by focus on outpatient procedures and streamlined surgical services,
Speak to an Analystto discuss market opportunities.
North America: Market Dominance Led by Adoption of Advanced Eye Surgery and Vision Correction Technologies
The North America cataract surgery devices market accounted for the largest regional share of 38.31% in 2025. Growth is linked to the introduction of advanced intraocular lenses and surgical technologies that improve vision correction and expand treatment options for cataract patients.
The United States market is moving toward intraocular lenses that address a wider range of visual needs after cataract surgery. The U.S. FDA approved Johnson & Johnson’s TECNIS PureSee extended depth of focus lens, with commercial availability planned for later that year. The lens is designed to improve intermediate vision while maintaining distance vision. Its rollout provides surgeons with another option for patients seeking greater visual range after surgery.
Canada’s National Strategy for Eye Care identifies recent advances in femtosecond laser-assisted cataract surgery, customizable intraocular lenses, and artificial intelligence as technologies improving the efficiency and safety of cataract procedures. Health Canada also recognizes specific standards for intraocular lenses and lens removal devices.
Unlock Regional Insightsto access country-level data, & regional trends.
Asia Pacific: Market Growth Supported by Expanding Cataract Surgery Programs and Advanced Ophthalmic Care
The Asia Pacific cataract surgery devices market is expected to grow at a CAGR of 5.38% during the forecast period, showcasing the fastest-growing regional market.
The India cataract surgery devices market is supported by the expansion of cataract surgery access and advanced ophthalmic procedures. Operation DRISHTI conducted a mega-eye surgical camp in Jharkhand, where more than 260 cataract surgeries were performed using advanced ophthalmic equipment, including phacoemulsification systems.
The China cataract surgery devices market is supported by national efforts to expand cataract treatment and ophthalmic infrastructure. China’s latest eye care plan targets a cataract surgery rate above 4,000 operations per million people and aims for all counties to have the capability to perform cataract surgery.
The Japan cataract surgery devices market is supported by the continued high volume of cataract procedures and outpatient ophthalmic care. A nationwide Japanese study using National Database of Health Insurance Claims data is examining cataract surgery volumes across healthcare facilities and outpatient versus inpatient procedures, providing updated evidence on the country’s cataract surgery landscape.
Latin America: Market Growth Acompanied by Modern Cataract Surgery Techniques and Innovative Intraocular Lens Technology
The Middle East and Africa cataract surgery devices market is expected to grow at a CAGR of 4.56% during the forecast period. In the UAE, Burjeel Medical City launched the Burjeel Eye Institute, offering cataract surgery and vision correction alongside advanced diagnostic and surgical technologies. This development expands access to specialized ophthalmic care and creates opportunities for cataract surgery devices. In South Africa, specialized ophthalmic equipment valued at over USD 14,000 was handed over to McCord Provincial Eye Hospital to support eye care, including cataract surgeries. The equipment donation strengthens surgical capacity and access to sight-restoring procedures.
Latin America: Market Growth Supported by Expansion of Public Healthcare System
The Latin America cataract surgery devices market is expected to grow at a CAGR of 4.31% during the forecast period. In Brazil, the Ministry of Health announced that the public healthcare system (SUS) would incorporate a combined procedure for cataract and glaucoma treatment, expanding access to advanced ophthalmic surgery. Mexico’s cataract surgery devices market has growth potential as hospitals and eye care centers expand access to cataract treatment and upgrade ophthalmic surgical equipment. Wider use of phacoemulsification systems, ophthalmic surgical instruments, and advanced intraocular lenses could help improve surgical efficiency and provide patients with more options for postoperative vision correction.
Europe: Market Growth Reflecting Precision Cataract Surgery and Next-Generation Intraocular Lens Technology
The Europe cataract surgery devices market is expected to grow at a CAGR of 3.64% during the forecast period. Germany’s Federal Joint Committee framework extended the reimbursability of several ophthalmic surgical products used during cataract extraction and intraocular lens implantation, including DuoVisc, ProVisc, and VISCOAT, with some products covered through 2030.
The UK cataract surgery devices market is supported by the large volume of cataract procedures performed through the NHS and continued evaluation of intraocular lens technologies. NICE initiated a HealthTech evaluation of monofocal intraocular lenses, with final guidance expected in March 2027. NHS hospitals are also investing in newer cataractsurgery platforms, with Queen Victoria Hospital introducing the UNITY cataract surgery platform in September 2026.
The critical care diagnostics market competitive landscape is moderately consolidated, with established diagnostic companies, clinical laboratory technology providers, and point-of-care testing manufacturers. Key players such asAbbott (US), F. Hoffmann-La Roche Ltd. (Switzerland), Siemens Healthineers AG (Germany), Randox Laboratories Ltd. (UK), BD (US), and bioMérieux SA (France) are estimated to account for approximately 39% of the global cataract surgery device market share.
Established players compete mainly through diagnostic accuracy, rapid testing technologies, automated analyzers, broad test portfolios, and global distribution networks. Emerging and regional players in the critical care diagnostics market ecosystem focus on specialized testing solutions, cost-effective diagnostic systems, and portable analyzers.
September 2026: Lupin received tentative approval from the U.S. FDA for its Apixaban Oral Suspension 1.25 mg/mL.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Automated Breast Ultrasound System Market Size, Share, 2034
Alimentary Tract Implant Market Size, Share, Growth, 2034
Critical Care Diagnostics Market Size, Share, Growth, Analysis, 2034
Defibrillator Market Size, Share, Growth, Analysis, Report, 2034
Creatine Kinase Reagent Market Size, Share, Growth, 2034
We are featured on:
sales@straitsresearch.com